Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in Japan

about

Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in Japan

Item

http://www.wikidata.org/entity/Q36071963

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Difference in efficacy of prot ...... s maintenance therapy in Japan

@ast

Difference in efficacy of prot ...... s maintenance therapy in Japan

@en

type

Item

label

Difference in efficacy of prot ...... s maintenance therapy in Japan

@ast

Difference in efficacy of prot ...... s maintenance therapy in Japan

@en

prefLabel

Difference in efficacy of prot ...... s maintenance therapy in Japan

@ast

Difference in efficacy of prot ...... s maintenance therapy in Japan

@en

P1476

Difference in efficacy of prot ...... s maintenance therapy in Japan

@en

P2093

A Nagahara

http://www.w3.org/2001/XMLSchema#string

D Asaoka

http://www.w3.org/2001/XMLSchema#string

H Sasaki

http://www.w3.org/2001/XMLSchema#string

H Ueyama

http://www.w3.org/2001/XMLSchema#string

K Matsumoto

http://www.w3.org/2001/XMLSchema#string

M Hojo

http://www.w3.org/2001/XMLSchema#string

N Sakamoto

http://www.w3.org/2001/XMLSchema#string

S Watanabe

http://www.w3.org/2001/XMLSchema#string

T Osada

http://www.w3.org/2001/XMLSchema#string

T Shibuya

http://www.w3.org/2001/XMLSchema#string

P2860

Gastro-esophageal reflux disease and obesity, where is the link?

Impact of body mass index and gender on quality of life in patients with gastroesophageal reflux disease.

Minimal changes in reflux esophagitis: red ones and white ones.

Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan.

Systematic review: persistence and severity in gastro-oesophageal reflux disease.

Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group

A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6 months for long-term maintenance with omeprazole 20 mg in patients with gastroesophageal reflux disease in Japan.

Proton pump inhibitor resistance, the real challenge in gastro-esophageal reflux disease.

Esomeprazole 20 mg on-demand is more acceptable to patients than continuous lansoprazole 15 mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND Study.

A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.

P304

53-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26435648

http://www.w3.org/2001/XMLSchema#string

P921

gastroesophageal reflux disease

P932

4574588

http://www.w3.org/2001/XMLSchema#string